Petra Marcella Françoise Blom

Title: Petra Marcella Françoise Blom: Innovator in Cancer Imaging

Introduction

Petra Marcella Françoise Blom is a notable inventor based in Destelbergen, Belgium. He has made significant contributions to the field of cancer imaging through his innovative work on radiolabeled compounds. His research focuses on enhancing the diagnosis and treatment of various cancers influenced by epidermal growth factor receptors (EGFR).

Latest Patents

Petra Blom holds a patent for a radiolabeled macrocyclic EGFR inhibitor. This invention relates to 18-Fluor radiolabeled macrocyclic quinazoline compounds, which serve as positron emission tomography (PET) tracers for imaging EGFR. The patent outlines their application in in vivo diagnosis, preclinical and clinical tumor imaging, and patient stratification based on the mutational status of EGFR. It also discusses methods for preparing these radiotracers and their relevance to cancers such as non-small cell lung cancer, pancreatic cancer, and breast cancer, among others.

Career Highlights

Throughout his career, Petra Blom has been associated with Oncodesign SA, a company dedicated to advancing cancer research and treatment. His work has contributed to the development of innovative diagnostic tools that improve patient outcomes.

Collaborations

Petra has collaborated with notable colleagues, including Jan Marie Cyriel Jozef Hoflack and Cyril Berthet, to further enhance the impact of his research in the field of oncology.

Conclusion

Petra Marcella Françoise Blom's contributions to cancer imaging through his patented inventions highlight the importance of innovation in medical research. His work continues to pave the way for advancements in the diagnosis and treatment of various cancers.